EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Third Harmonic Bio's Enterprise Value is $211.74 Mil.
Third Harmonic Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-20.43 Mil. Therefore, Third Harmonic Bio's EV-to-FCF for today is -10.37.
The historical rank and industry rank for Third Harmonic Bio's EV-to-FCF or its related term are showing as below:
THRD'
s EV-to-FCF Range Over the Past 10 Years
Min: -10.9 Med: 0 Max: 2.36
Current: -10.37
During the past 4 years, the highest EV-to-FCF of Third Harmonic Bio was 2.36. The lowest was -10.90. And the median was 0.00.
THRD's EV-to-FCF is ranked worse than 100% of 392
companies
in the Biotechnology industry
Industry Median: 4.57
vs THRD: -10.37
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Third Harmonic Bio's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Third Harmonic Bio's EV-to-FCF
For the Biotechnology subindustry, Third Harmonic Bio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Third Harmonic Bio's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Third Harmonic Bio's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Third Harmonic Bio's EV-to-FCF falls into.
Third Harmonic Bio's current Enterprise Value is $211.74 Mil.
Third Harmonic Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Third Harmonic Bio (NAS:THRD) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Third Harmonic Bio's PE Ratio for today is calculated as:
Third Harmonic Bio's share price for today is $11.70.
Third Harmonic Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.950.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Third Harmonic Bio EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Third Harmonic Bio's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Third Harmonic Bio (Third Harmonic Bio) Business Description
Third Harmonic Bio Inc is a clinical-stage company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases.. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
THRD has been successfully added to your 